The Efficacy and Safety of Surgical Treatment in Type IVa Congenital Biliary Dilation: A Multi-center Cohort Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients who have been diagnosed with Todani type IVa BD.
• Patients aged between 0 and 80 years old, regardless of gender.
• First-time receipt of surgery.
Locations
Other Locations
China
Beijing Tsinghua Changgung Hospital
RECRUITING
Beijing
Contact Information
Primary
Changzhen Yang, MD
ycz23@mail.tsinghua.edu.cn
+86 18810915262
Backup
Shuo Jin, PhD
jsa01263@btch.edu.cn
+86 18611172714
Time Frame
Start Date: 2025-07-14
Estimated Completion Date: 2035-07-01
Participants
Target number of participants: 1500
Treatments
Liver Resection Group
This group included patients with type IVa BD who underwent liver resection, extrahepatic bile duct resection and Roux-en-Y hepaticojejunostomy
Hepaticojejunostomy Group
This group included patients with type IVa BD who underwent extrahepatic bile duct resection and Roux-en-Y hepaticojejunostomy
Related Therapeutic Areas
Sponsors
Leads: Beijing Tsinghua Chang Gung Hospital